Martin P, Heiskari N, Pajari H, Grönhagen-Riska C, Kääriäinen H, Koskimies O, Tryggvason K
Biocenter Oulu and Department of Biochemistry, University of Oulu, Oulu, Finland.
Hum Mutat. 2000 Jun;15(6):579. doi: 10.1002/1098-1004(200006)15:6<579::AID-HUMU13>3.0.CO;2-K.
Alport syndrome (AS) is a hereditary kidney disorder, mainly caused by mutations in the X-chromosomal gene (COL4A5) encoding the type IV collagen a5 chain. In this study, detection of COL4A5 mutations was performed in 17 Finnish Alport syndrome families. Regions around the 51 previously known exons, as well as the two recently characterized exons 41A and 41B in COL4A5, were PCR-amplified from the patient DNA. Direct sequencing of the amplified products was performed and mutations were found in 12 families. None of the mutations involved exons 41A or 41B. Three of the mutations were potential splicing mutations, two of which were studied at the mRNA level. Seven of the mutations were single base substitutions, and two were deletions. In five families, no mutations were found.
奥尔波特综合征(AS)是一种遗传性肾脏疾病,主要由编码IV型胶原α5链的X染色体基因(COL4A5)突变引起。在本研究中,对17个芬兰奥尔波特综合征家族进行了COL4A5突变检测。从患者DNA中PCR扩增COL4A5中51个先前已知外显子周围的区域以及最近鉴定的两个外显子41A和41B。对扩增产物进行直接测序,在12个家族中发现了突变。没有一个突变涉及外显子41A或41B。其中三个突变是潜在的剪接突变,其中两个在mRNA水平进行了研究。七个突变是单碱基替换,两个是缺失。在五个家族中未发现突变。